Mark Hinds

Statistics

Publications

Citations

295

H-Index

Active since

1993

Affiliations

University of Waterloo(Current)

Cancer Trials Australia

UNSW Sydney

Mark Hinds is an author at University of Waterloo specializing in meibomian gland secretion abnormalities, meibomian gland function assessment, and ocular surface disease.

Publications per year

1993–2024

Publications

Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation.

Scott I. Bearman, Garnet L. Anderson, Motomi Mori et al. · Journal of Clinical Oncology · 1993 · 256 citations

Medicine, Internal Medicine, Surgery +16

Efficacy and safety of AZR-MD-001 selenium sulfide ophthalmic ointment in adults with meibomian gland dysfunction: A vehicle-controlled, randomized clinical trial

Stephanie L. Watson, Lyndon Jones, Fiona Stapleton et al. · The Ocular Surface · 2023 · 23 citations · Full text

Pharmacy, Ophthalmology, Pharmacotherapy +16

Efficacy and safety of AZR-MD-001 selenium sulfide ophthalmic ointment in adults with meibomian gland dysfunction over six months of treatment: A Phase 2, vehicle-controlled, randomized extension trial

Laura E. Downie, Jennifer P. Craig, Fiona Stapleton et al. · The Ocular Surface · 2024 · 16 citations · Full text

Pharmacy, Ophthalmology, Pharmacotherapy +17

1–3 of 3